Your browser doesn't support javascript.
loading
A real-world comparison of cardiovascular, medical and costs outcomes in new users of SGLT2 inhibitors versus GLP-1 agonists.
Poonawalla, Insiya B; Bowe, Andy T; Tindal, Michael C; Meah, Yunus A; Schwab, Phil.
Affiliation
  • Poonawalla IB; Humana Healthcare Research, Inc., Louisville, KY, United States. Electronic address: IPoonawalla@humana.com.
  • Bowe AT; Humana Healthcare Research, Inc., Louisville, KY, United States.
  • Tindal MC; Humana Inc., Louisville, KY, United States.
  • Meah YA; Humana Inc., Louisville, KY, United States.
  • Schwab P; Humana Healthcare Research, Inc., Louisville, KY, United States.
Diabetes Res Clin Pract ; 175: 108800, 2021 May.
Article in En | MEDLINE | ID: mdl-33845052
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glucagon-Like Peptide 1 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Res Clin Pract Journal subject: ENDOCRINOLOGIA Year: 2021 Document type: Article Country of publication: Ireland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glucagon-Like Peptide 1 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Res Clin Pract Journal subject: ENDOCRINOLOGIA Year: 2021 Document type: Article Country of publication: Ireland